Liminatus Pharma, Inc. Warrants (LIMNW) Stock Price
Liminatus Pharma, Inc. Warrants (NASDAQ: LIMNW) last traded at $0.0451, down 22.64% on the session. The quote above updates while this page is open; the figures below are drawn from Liminatus Pharma, Inc. Warrants’s own filings and are restated only when a new one is published.
Liminatus Pharma, Inc. Warrants (LIMNW) company overview
Liminatus Pharma, Inc. Warrants trades on NASDAQ under the ticker LIMNW. Its market capitalisation is $3.03 million.
LIMNW valuation
Valuation measures for Liminatus Pharma, Inc. Warrants, derived from the latest quote and its most recent SEC filing.
Market cap
$3.03M
Price / book
10.08
LIMNW financials
Trailing-twelve-month figures tagged in Liminatus Pharma, Inc. Warrants's XBRL filings with the SEC.
Net income (TTM)
-$12.52M
Return on equity
-4165.92%
LIMNW trading statistics
Range and volume for LIMNW over the past 52 weeks.
52-week high
$0.0451
52-week low
$0.0451
Volume
5.0K
Average volume
5.0K
Previous close
$0.0583
Liminatus Pharma, Inc. Warrants (LIMNW) FAQs
What is the LIMNW stock price today?
Liminatus Pharma, Inc. Warrants (LIMNW) last traded at $0.05, down 22.64% on the session. FurlPay quotes LIMNW from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is LIMNW listed on?
Liminatus Pharma, Inc. Warrants is listed on NASDAQ under the ticker symbol LIMNW.
What is Liminatus Pharma, Inc. Warrants's market cap?
Liminatus Pharma, Inc. Warrants has a market capitalisation of $3.03 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is LIMNW's 52-week range?
Over the past 52 weeks LIMNW has traded between $0.05 and $0.05.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001971387), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.